We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle.
- Authors
Salinas, Nichole D.; Ma, Rui; Dickey, Thayne H.; McAleese, Holly; Ouahes, Tarik; Long, Carole A.; Miura, Kazutoyo; Lambert, Lynn E.; Tolia, Niraj H.
- Abstract
Malaria transmission-blocking vaccines (TBVs) reduce disease transmission by breaking the continuous cycle of infection between the human host and the mosquito vector. Domain 1 (D1) of Pfs230 is a leading TBV candidate and comprises the majority of transmission-reducing activity (TRA) elicited by Pfs230. Here we show that the fusion of Pfs230D1 to a 60-copy multimer of the catalytic domain of dihydrolipoyl acetyltransferase protein (E2p) results in a single-component nanoparticle composed of 60 copies of the fusion protein with high stability, homogeneity, and production yields. The nanoparticle presents a potent human transmission-blocking epitope within Pfs230D1, indicating the antigen is correctly oriented on the surface of the nanoparticle. Two vaccinations of New Zealand White rabbits with the Pfs230D1 nanoparticle elicited a potent and durable antibody response with high TRA when formulated in two distinct adjuvants suitable for translation to human use. This single-component nanoparticle vaccine may play a key role in malaria control and has the potential to improve production pipelines and the cost of manufacturing of a potent and durable TBV.
- Subjects
NANOPARTICLES; MALARIA vaccines; INSECTICIDE resistance; MALARIA; MALARIA prevention; PROTEIN stability; MOSQUITO vectors; CATALYTIC domains; MOSQUITO control
- Publication
NPJ Vaccines, 2023, Vol 8, Issue 1, p1
- ISSN
2059-0105
- Publication type
Article
- DOI
10.1038/s41541-023-00709-8